Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
Sales | 8,506,000 | 9,255,000 | 7,996,000 | 7,296,000 | 7,747,000 |
Cost of Goods | 1,058,000 | 1,146,000 | 1,026,000 | 902,000 | 940,000 |
Gross Profit | 7,448,000 | 8,109,000 | 6,970,000 | 6,394,000 | 6,807,000 |
Operating Expenses | 4,049,000 | 4,773,000 | 4,016,000 | 4,065,000 | 3,835,000 |
Operating Income | 3,399,000 | 3,336,000 | 2,954,000 | 2,329,000 | 2,972,000 |
Other Income | -183,000 | 97,000 | -54,000 | 44,000 | 88,000 |
Pre-tax Income | 3,216,000 | 3,433,000 | 2,900,000 | 2,373,000 | 3,060,000 |
Income Tax | 761,000 | 742,000 | 630,000 | 480,000 | 747,000 |
Net Income Continuous | 2,455,000 | 2,687,000 | 2,269,000 | 1,893,000 | 2,312,000 |
Net Income Discontinuous | 2,240,000 | 169,000 | 81,000 | 64,000 | 61,000 |
Net Income | $4,665,000 | $2,856,000 | $2,350,000 | $1,957,000 | $1,963,000 |
EPS Basic Total Ops | 0.76 | 0.46 | 0.39 | 0.31 | 0.32 |
EPS Basic Continuous Ops | 0.40 | 0.43 | 0.38 | 0.30 | 0.38 |
EPS Basic Discontinuous Ops | 0.36 | 0.03 | 0.01 | 0.01 | 0.01 |
EPS Diluted Total Ops | 0.76 | 0.46 | 0.38 | 0.31 | 0.31 |
EPS Diluted Continuous Ops | 0.40 | 0.43 | 0.37 | 0.30 | 0.37 |
EPS Diluted Discontinuous Ops | 0.36 | 0.03 | 0.01 | 0.01 | 0.01 |
EBITDA(a) | $3,668,000 | $3,630,000 | $3,204,000 | $2,569,000 | $3,218,000 |